Perspectives on Risk and Regulation: The FDA at 100
Perspectives on Risk and Regulation: The FDA at 100 brings together the viewpoints of Food and Drug Administration officials and industry leaders on the future of regulating food, drugs, medical devices, and dietary supplements. In a period of rapid scientific and market changes the success of regulation in these areas increasingly hinges on communication and collaboration between the FDA and the private sector. By situating forward-looking perspectives of agency leaders and industry representatives within FDA’s regulatory history, this volume presents readers with new tools for evaluating policy recommendations and will better equip the public and experts to assess pressing regulatory issues.
Keywords: Private Sector;
Governing Rules, Regulations, and Reforms;
Health Care and Treatment;
Business and Government Relations;
Risk and Uncertainty;